Share-based compensation - Schedule of Share Options and Other Equity Instruments (Details)
|
12 Months Ended |
|
|
Dec. 31, 2023
share
shares
year
yr
$ / shares
|
Dec. 31, 2023
share
shares
year
yr
$ / shares
SFr / shares
|
Dec. 31, 2022
share
shares
year
$ / shares
|
Dec. 31, 2022
share
shares
year
$ / shares
SFr / shares
|
Dec. 31, 2021
$ / shares
|
| LTPP 2018 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares |
$ 0.05
|
$ 0.05
|
$ 0.04
|
$ 0.04
|
$ 0.04
|
| Weighted average exercise price of share options forfeited in share-based payment arrangement (USD per share) | SFr / shares |
|
$ 0.11
|
|
$ 0.11
|
|
| Weighted average exercise price of share options exercised in share-based payment arrangement (USD per share) | $ / shares |
0.03
|
|
0.03
|
|
|
| Weighted average exercise price of share options exercisable in share-based payment arrangement (USD per share) | $ / shares |
$ 0.05
|
$ 0.05
|
$ 0.03
|
$ 0.03
|
|
| LTIP 2018 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Share options outstanding at beginning of period (in shares) |
360,000
|
360,000
|
865,000
|
865,000
|
|
| Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares |
$ 5.53
|
$ 5.53
|
$ 4.59
|
$ 4.59
|
3.26
|
| Share options granted (in shares) |
0
|
0
|
0
|
0
|
|
| Share options forfeited (in shares) |
0
|
0
|
0
|
0
|
|
| Share options exercised (in shares) |
(62,500)
|
(62,500)
|
(505,000)
|
(505,000)
|
|
| Weighted average exercise price of share options exercised in share-based payment arrangement (USD per share) | $ / shares |
$ 0.11
|
|
$ 2.32
|
|
|
| Share options outstanding at end of period (in shares) |
297,500
|
297,500
|
360,000
|
360,000
|
|
| Weighted average remaining contractual life of outstanding share options |
0 years
|
0 years
|
0 years
|
0 years
|
|
| Share options exercisable (in shares) |
297,500
|
297,500
|
360,000
|
360,000
|
|
| Weighted average exercise price of share options exercisable in share-based payment arrangement (USD per share) | $ / shares |
$ 5.53
|
$ 5.53
|
$ 4.59
|
$ 4.59
|
|
| LTIP 2020 | Class A shares |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Share options outstanding at beginning of period (in shares) |
4,939,564
|
4,939,564
|
5,687,811
|
5,687,811
|
|
| Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares |
$ 8.28
|
$ 8.28
|
$ 8.28
|
$ 8.28
|
8.04
|
| Share options granted (in shares) |
0
|
0
|
2,694,843
|
2,694,843
|
|
| Weighted average exercise price of share options granted in share-based payment arrangement (USD per share) | $ / shares |
|
|
$ 8.28
|
|
|
| Share options forfeited (in shares) |
0
|
0
|
(2,500)
|
(2,500)
|
|
| Weighted average exercise price of share options forfeited in share-based payment arrangement (USD per share) | SFr / shares |
|
$ 7.89
|
|
$ 7.73
|
|
| Share options exercised (in shares) |
(1,395,873)
|
(1,395,873)
|
(3,440,590)
|
(3,440,590)
|
|
| Weighted average exercise price of share options exercised in share-based payment arrangement (USD per share) | $ / shares |
$ 8.29
|
|
$ 7.87
|
|
|
| Share options outstanding at end of period (in shares) |
3,543,691
|
3,543,691
|
4,939,564
|
4,939,564
|
|
| Weighted average remaining contractual life of outstanding share options |
0 years
|
0 years
|
0 years
|
0 years
|
|
| Share options exercisable (in shares) |
3,543,691
|
3,543,691
|
4,939,564
|
4,939,564
|
|
| Weighted average exercise price of share options exercisable in share-based payment arrangement (USD per share) | $ / shares |
$ 8.28
|
$ 8.28
|
$ 8.28
|
$ 8.28
|
|
| LTIP 2020 | Class B |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Share options outstanding at beginning of period (in shares) |
15,812,500
|
15,812,500
|
10,552,670
|
10,552,670
|
|
| Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares |
$ 0.77
|
$ 0.77
|
$ 0.77
|
$ 0.77
|
$ 0.77
|
| Share options granted (in shares) |
0
|
0
|
5,259,830
|
5,259,830
|
|
| Weighted average exercise price of share options granted in share-based payment arrangement (USD per share) | $ / shares |
|
|
$ 0.77
|
|
|
| Share options forfeited (in shares) |
0
|
0
|
0
|
0
|
|
| Share options exercised (in shares) |
0
|
0
|
0
|
0
|
|
| Share options outstanding at end of period (in shares) |
15,812,500
|
15,812,500
|
15,812,500
|
15,812,500
|
|
| Weighted average remaining contractual life of outstanding share options |
0 years
|
0 years
|
0 years
|
0 years
|
|
| Share options exercisable (in shares) |
15,812,500
|
15,812,500
|
15,812,500
|
15,812,500
|
|
| Weighted average exercise price of share options exercisable in share-based payment arrangement (USD per share) | $ / shares |
$ 0.77
|
$ 0.77
|
$ 0.77
|
$ 0.77
|
|
| BoD 2019 |
|
|
|
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) |
0
|
0
|
16,833
|
16,833
|
|
| Instruments granted (in shares) |
44,966
|
44,966
|
31,612
|
31,612
|
|
| Other equity instruments forfeited (in shares) |
0
|
0
|
0
|
0
|
|
| Other equity instruments exercised (in shares) |
(44,966)
|
(44,966)
|
(48,445)
|
(48,445)
|
|
| Other equity instruments outstanding at end of period (in shares) |
0
|
0
|
0
|
0
|
|
| SLIA 2019 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Maximum term of awards granted | year |
1.5
|
1.5
|
4.0
|
4.0
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) |
4,700,000
|
4,700,000
|
4,700,000
|
4,700,000
|
|
| Instruments granted (in shares) |
0
|
0
|
0
|
0
|
|
| Other equity instruments forfeited (in shares) |
0
|
0
|
0
|
0
|
|
| Other equity instruments exercised (in shares) |
0
|
0
|
0
|
0
|
|
| Other equity instruments outstanding at end of period (in shares) |
4,700,000
|
4,700,000
|
4,700,000
|
4,700,000
|
|
| Weighted average contractual life remaining | year |
1.1
|
1.1
|
2.1
|
2.1
|
|
| Other equity instruments exercisable (in shares) |
0
|
0
|
0
|
0
|
|
| Founders' Plan 2021 |
|
|
|
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) | shares |
53,331
|
53,331
|
123,328
|
123,328
|
|
| Instruments granted (in shares) | shares |
17,998
|
17,998
|
0
|
0
|
|
| Other equity instruments forfeited (in shares) | shares |
(20,331)
|
(20,331)
|
0
|
0
|
|
| Other equity instruments exercised (in shares) | shares |
(17,998)
|
(17,998)
|
(69,997)
|
(69,997)
|
|
| Other equity instruments outstanding at end of period (in shares) | shares |
33,000
|
33,000
|
53,331
|
53,331
|
|
| Other equity instruments exercisable (in shares) | shares |
33,000
|
33,000
|
53,331
|
53,331
|
|
| Tax Recognition 2022 |
|
|
|
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) | shares |
0
|
0
|
0
|
0
|
|
| Instruments granted (in shares) | shares |
7,205
|
7,205
|
127,297
|
127,297
|
|
| Other equity instruments forfeited (in shares) | shares |
0
|
0
|
0
|
0
|
|
| Other equity instruments exercised (in shares) | shares |
(7,205)
|
(7,205)
|
(127,297)
|
(127,297)
|
|
| Other equity instruments outstanding at end of period (in shares) | shares |
0
|
0
|
0
|
0
|
|
| Phantom options | LTPP 2018 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Share options outstanding at beginning of period (in shares) | shares |
1,248,750
|
1,248,750
|
2,026,250
|
2,026,250
|
|
| Share options granted (in shares) |
0
|
0
|
0
|
0
|
|
| Share options forfeited (in shares) | shares |
(7,500)
|
(7,500)
|
(31,250)
|
(31,250)
|
|
| Share options exercised (in shares) | shares |
(680,118)
|
(680,118)
|
(746,250)
|
(746,250)
|
|
| Share options outstanding at end of period (in shares) | shares |
561,132
|
561,132
|
1,248,750
|
1,248,750
|
|
| Weighted average remaining contractual life of outstanding share options |
0 years
|
0 years
|
1 month 6 days
|
1 month 6 days
|
|
| Maximum term of awards granted | year |
|
|
0.2
|
0.2
|
|
| Share options exercisable (in shares) | shares |
561,132
|
561,132
|
1,038,750
|
1,038,750
|
|
| Phantom shares | OEPP 2018 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Maximum term of awards granted | year |
|
|
0
|
0
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) |
15,000
|
15,000
|
130,000
|
130,000
|
|
| Instruments granted (in shares) |
0
|
0
|
0
|
0
|
|
| Other equity instruments forfeited (in shares) |
0
|
0
|
0
|
0
|
|
| Other equity instruments exercised (in shares) |
(8,750)
|
(8,750)
|
(115,000)
|
(115,000)
|
|
| Other equity instruments outstanding at end of period (in shares) |
6,250
|
6,250
|
15,000
|
15,000
|
|
| Other equity instruments exercisable (in shares) |
6,250
|
6,250
|
15,000
|
15,000
|
|
| Restricted share units (RSU) | LTIP 2021 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Maximum term of awards granted |
2.2
|
2.2
|
1.2
|
1.2
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) | shares |
7,165
|
7,165
|
1,588
|
1,588
|
|
| Instruments granted (in shares) | shares |
896,311
|
896,311
|
116,551
|
116,551
|
|
| Other equity instruments forfeited (in shares) | shares |
(37,393)
|
(37,393)
|
(507)
|
(507)
|
|
| Other equity instruments exercised (in shares) | shares |
(55,829)
|
(55,829)
|
(110,467)
|
(110,467)
|
|
| Other equity instruments outstanding at end of period (in shares) | shares |
810,254
|
810,254
|
7,165
|
7,165
|
|
| Weighted average contractual life remaining | year |
1.0
|
1.0
|
0.7
|
0.7
|
|
| Other equity instruments exercisable (in shares) | shares |
455
|
455
|
0
|
0
|
|
| Performance share units (PSU) | LTIP 2021 |
|
|
|
|
|
| Share Options [Abstract] |
|
|
|
|
|
| Maximum term of awards granted |
2.2
|
2.2
|
2.2
|
2.2
|
|
| Other Equity Instruments [Abstract] |
|
|
|
|
|
| Other equity instruments outstanding at beginning of period (in shares) | shares |
37,808
|
37,808
|
0
|
0
|
|
| Instruments granted (in shares) | shares |
1,034,815
|
1,034,815
|
37,808
|
37,808
|
|
| Other equity instruments forfeited (in shares) | shares |
(5,408)
|
(5,408)
|
0
|
0
|
|
| Other equity instruments exercised (in shares) | shares |
0
|
0
|
0
|
0
|
|
| Other equity instruments outstanding at end of period (in shares) | shares |
1,067,215
|
1,067,215
|
37,808
|
37,808
|
|
| Weighted average contractual life remaining | year |
1.7
|
1.7
|
2.2
|
2.2
|
|
| Other equity instruments exercisable (in shares) | shares |
0
|
0
|
0
|
0
|
|